Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
ENGASE encodes a cytosolic enzyme which catalyzes the hydrolysis of peptides and proteins with mannose modifications to produce free oligosaccharides. De plus, nous expédions ENGASE Anticorps (16) et ENGASE Kits (6) et beaucoup plus de produits pour cette protéine.
Showing 4 out of 4 products:
In patients with autosomal dominant polycystic kidney disease, urinary NAGase was correlated with urinary ET-1 (Montrer EDN1 Protéines) which was inversely associated with eGFR (Montrer EGFR Protéines) and positively correlated with total kidney volume.
Serological N-acetyl-glucosaminidase (Montrer NAGLU Protéines), telomere length, and the UCP2 (Montrer UCP2 Protéines)-886G>A variant are independent risk factors for type 2 diabetes.
As the generation of the bulk of fOS is unaffected by co-down regulation of Ngly1p and Engase1p, alternative quantitatively important mechanisms must underlie the liberation of these fOS from either LLO or glycoproteins during protein N (Montrer NP Protéines)-glycosylation.
O-GlcNAcase (Montrer MGEA5 Protéines) expression is increased in erythrocytes from both individuals with pre-diabetes and individuals with less well-controlled diabetes.
involved in processing of free oligosaccharides in the cytosol; identification of the gene encoding human cytosolic ENGase
endo-beta-n-acetylglucosaminidase present in the synovial fluid of rheumatoid arthritis patients, may contribute to the depletion of glycosaminoglycans from cartilage allowing the invasion of synovial cells
identification of O-GlcNAcase (Montrer MGEA5 Protéines) as a caspase-3 (Montrer CASP3 Protéines) substrate with a novel caspase-3 (Montrer CASP3 Protéines) cleavage site and provide insight about O-GlcNAcase (Montrer MGEA5 Protéines) regulation during apoptosis.
These observations strongly suggest that the Ngly1 (Montrer NGLY1 Protéines)- or Ngly1 (Montrer NGLY1 Protéines)/Engase-deficient mice could serve as a valuable animal model for studies related to the pathogenesis of the NGLY1 (Montrer NGLY1 Protéines)-deficiency, and that cytoplasmic ENGase represents one of the potential therapeutic targets for this genetic disorder.
ENGase efficiently hydrolyzes phosphorylated oligosaccharides that are larger than Man4GlcNAc2-P, generating GlcNAc-1-P and neutral Gn1 (Montrer GYG1 Protéines)-type free oligosaccharides.
This gene encodes a cytosolic enzyme which catalyzes the hydrolysis of peptides and proteins with mannose modifications to produce free oligosaccharides.
, Di-N-acetylchitobiosyl beta-N-acetylglucosaminidase
, Mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase
, Cytosolic endo-beta-N-acetylglucosaminidase